Warning letter
Inova Health Care Services, Inova Blood Donor Services: warning letter of May 3, 2012
FDA warning letter 298919 · Baltimore District Office
Key facts
| Reference number | 298919 |
|---|---|
| Company | Inova Health Care Services, Inova Blood Donor Services |
| Subject | CGMP Regulation for Blood and Blood Products/Adulterated |
| Issue date | May 3, 2012 |
| Posted date | May 3, 2012 |
| Issuing office | Baltimore District Office |
| Product type | Biologics |
| CFR sections cited | 606.171(b), 606.60(a) |
| Inspection city | Sterling |
| Inspection ZIP | 20166 |
| Inspection start date | Jan 23, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: